SEC Company Response from Predictive Oncology Inc. (POAI) (CIK 0001446159) (AGPU) — Nov 15, 2019
Predictive Oncology Inc. (POAI) (CIK 0001446159)
Date: Nov. 15, 2019 · CIK: 0001446159 · Accession: 0001171843-19-007597
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-234366
Letter
Re: Predictive Oncology Inc.
November 15, 2019
BY EDGAR
United States Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549
Attention: Mr. Paul Fischer, Esq.
Registration Statement on Form S-1
File No. 333-234366
Request for Acceleration
Ladies and Gentlemen:
In accordance with Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Predictive Oncology Inc., a Delaware corporation (the “Registrant”), hereby requests that the effectiveness of the above-referenced Registration Statement on Form S-1 (the “Registration Statement”), be accelerated so that it will be declared effective at 3:00 p.m. Eastern Standard Time on November 19, 2019, or as soon thereafter as practicable.
Very truly yours,
Predictive Oncology Inc.
Show Raw Text
CORRESP
1
filename1.htm
November 15, 2019
BY EDGAR
United States Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549
Attention: Mr. Paul Fischer, Esq.
Re:
Predictive Oncology Inc.
Registration Statement on Form S-1
File No. 333-234366
Request for Acceleration
Ladies and Gentlemen:
In accordance with Rule 461 of the General Rules and Regulations
under the Securities Act of 1933, as amended, Predictive Oncology Inc., a Delaware corporation (the “Registrant”),
hereby requests that the effectiveness of the above-referenced Registration Statement on Form S-1 (the “Registration Statement”),
be accelerated so that it will be declared effective at 3:00 p.m. Eastern Standard Time on November 19, 2019, or as soon thereafter
as practicable.
Very truly yours,
Predictive Oncology Inc.
By:
/s/ Bob Myers
Name: Bob Myers
Title: Chief Financial Officer